Haruna, Miya <br/><br/>
Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.  [electronic resource] 

 -  Biological & pharmaceutical bulletin  2020 
 - 399-403 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1347-5215 
<br/><br/><label>Standard No.: </label>10.1248/bpb.b19-00702  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Antineoplastic Agents<br/>CD11 Antigens--metabolism<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Chemokines--metabolism<br/>Combined Modality Therapy<br/>Cytokines--metabolism<br/>Docetaxel--pharmacology<br/>Epidermal Growth Factor--antagonists & inhibitors<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>HMGB1 Protein--blood<br/>Humans<br/>Integrin alpha Chains--metabolism<br/>Male<br/>Mutation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Transcriptional Activation--drug effects